Radiotherapy DosageRadiotherapyRadiotherapy, ConformalRadiotherapy, AdjuvantRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyCombined Modality TherapyDose FractionationRadiation InjuriesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedTreatment OutcomeRadiation OncologyRadiosurgeryDose-Response Relationship, RadiationBrachytherapyHead and Neck NeoplasmsNeoplasm Recurrence, LocalGene DosageNeoplasm StagingDosage Compensation, GeneticChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsBrain NeoplasmsDisease-Free SurvivalCarcinoma, Squamous CellNasopharyngeal NeoplasmsRetrospective StudiesRadiation ToleranceSurvival RateFollow-Up StudiesOrgans at RiskSurvival AnalysisLung NeoplasmsSubcellular FractionsRadiation-Sensitizing AgentsPrognosisDosage FormsTime FactorsRectal NeoplasmsCisplatinRadiation DosageChemotherapy, AdjuvantParticle AcceleratorsCranial IrradiationRadiometryProstatic NeoplasmsRadiation PneumonitisBreast NeoplasmsPelvic NeoplasmsLaryngeal NeoplasmsMastectomy, SegmentalHodgkin DiseaseNeoplasms, Radiation-InducedRadiodermatitisTomography, X-Ray ComputedNeoplasmsHeavy Ion RadiotherapyVincristineAntineoplastic AgentsDacarbazineFluorouracilNeoplasms, Second PrimaryOrgan Sparing TreatmentsProcarbazineXerostomiaNeoadjuvant TherapyRadioisotope TeletherapyDrug Administration ScheduleAdenocarcinomaCobalt RadioisotopesProspective StudiesSpinal NeoplasmsPalliative CareCarcinoma, Non-Small-Cell LungLymphatic IrradiationCarcinomaUterine Cervical NeoplasmsRadiation-Protective AgentsGlioblastomaMechlorethamineKaplan-Meier EstimateDose-Response Relationship, DrugDoxorubicinBleomycinSalvage TherapyGliomaIridium RadioisotopesAntineoplastic Agents, AlkylatingCyclophosphamideMastectomyFeasibility StudiesEsophageal NeoplasmsLymphatic MetastasisPelvisTumor BurdenOsteoradionecrosisThoracic NeoplasmsVinblastine